Topic: Prep

5 chapters across the catalog

86: Pox Luck
2:12:50 - 2:19:52

86: Pox Luck

Immune System Debasement and the "Down-Low" Narrative

The hosts speculate on whether monkeypox is a true viral outbreak or an expression of weakened immune systems following mass COVID-19 vaccinations. They discuss the historical "down-low" narrative used during the AIDS crisis to explain the jump from the gay community to the Black heterosexual population. The conversation also touches on how future pandemics may be linked to climate change to justify further societal controls.

85: Overman
1:31:03 - 1:41:27

85: Overman

GINA Loopholes and the History of IQ Testing

The Genetic Information Nondiscrimination Act (GINA) is discussed as having significant loopholes regarding "gene-lining." This leads to a history of the IQ test, originally developed by Alfred Binet and Theodore Simon in 1905 to help struggling students. The hosts argue that the test was quickly corrupted for use at Ellis Island and in the military to create erroneous racial hierarchies and gatekeep elite opportunities.

69: Infektion
6:14 - 12:03

69: Infektion

AIDS History, Dr. Anthony Fauci and 1980s Marketing

A retrospective on the 40-year history of the AIDS epidemic highlights the roles of President Ronald Reagan and Dr. Anthony Fauci. The narrative explores the early stigma of the "gay disease" and the introduction of the drug AZT. Claims are made regarding the psychological impact of early marketing that suggested the virus could be transmitted through casual contact or doorknobs.

69: Infektion
15:06 - 19:34

69: Infektion

Pharmaceutical Marketing, PrEP and Demographic Targeting

The discussion examines the overrepresentation of Black women and gay men in modern pharmaceutical commercials for PrEP. Questions are raised about why these groups are targeted in advertising if the medical community considers the crisis "solved." The hosts debate whether modern HIV symptoms are a result of the virus or the treatments provided.

69: Infektion
26:41 - 34:19

69: Infektion

HIV Stigma, Drug Costs and Truvada Pricing

Despite medical advancements, a survey indicates that one-third of HIV-negative millennials still avoid physical contact with HIV-positive individuals. The discussion shifts to the high cost of Truvada, noting that a month's supply can cost $2,000 without insurance. The hosts question why life-saving preventative drugs are not provided for free if the goal is to "flatten the curve."